CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that it will be presenting at the BIO CEO & Investor Conference on Tuesday, February 12, 2008 at 11:00 am EST. The presentation will be webcast live and can be accessed on the Sirtris website (www.sirtrispharma.com) in the “Investor Relations” section. A replay will be available approximately twenty-four hours after the presentation and will be archived on the company’s website for two weeks.
